Zogenix (ZGNX:NASDAQ) Annual Reports & Investor Relations Material

Overview

Zogenix is a pharmaceutical company that focuses on creating innovative treatments for Central Nervous System (CNS) disorders. The company specializes in developing therapies for rare, orphan diseases that affect individuals' daily functioning. Zogenix is committed to providing effective alternatives for those who need them most.

Frequently Asked Questions

What is Zogenix's ticker?

Zogenix's ticker is ZGNX

What exchange is Zogenix traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Zogenix's headquarters?

They are based in Emeryville, California

How many employees does Zogenix have?

There are 51-200 employees working at Zogenix

What is Zogenix's website?

It is zogenix.com/company

What type of sector is Zogenix?

Zogenix is in the Healthcare sector

What type of industry is Zogenix?

Zogenix is in the Drug Manufacturers - Major industry

Who are Zogenix's peers and competitors?

The following five companies are Zogenix's industry peers:

- GSK

- AstraZeneca

- Hikma Pharmaceuticals

- Benchmark Holdings plc

- Boston Properties